author-photo

Solange Corriol-Rohou

AstraZeneca

10

Papers

24

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

The Role of Mobility Endpoints in Marketing Authorisation of Drugs: What Gets the EMA Moving?

2021 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (0)
Optimising paediatric medicines development in the EU through pragmatic approaches

2021 Clinical Pharmacology & Therapeutics
Show All
- Source
- Cite
- Save
Citations (3)
Objectively Measured Physical Activity as a COPD Clinical Trial Outcome.

2021 Chest
Show All
- Source
- Cite
- Save
Citations (0)
Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments.

2021 Thorax
Show All
- Source
- Cite
- Save
Citations (4)
Regulatory and health technology assessment advice on Post-licensing and Post-Launch Evidence Generation is a foundation for lifecycle data collection for medicines.

2020 British Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (10)
How is the Pharmaceutical Industry Structured to Optimize Pediatric Drug Development? Existing Pediatric Structure Models and Proposed Recommendations for Structural Enhancement

2020 Therapeutic Innovation & Regulatory Science
Show All
- Source
- Cite
- Save
Citations (1)
Orphan Medicines for Pediatric Use: A Focus on the European Union

2019 Clinical Therapeutics
Show All
- Source
- Cite
- Save
Citations (4)
Shared Learnings on the New EMA First-in-Human and Early Clinical Trial Guideline: Proceedings From a DIAlogue Session at DIA Europe 2018:

2019 Therapeutic Innovation & Regulatory Science
Show All
- Source
- Cite
- Save
Citations (0)